Adult CD1 mice were used for these experiments after approval was obtained by the IACUC of Weill Cornell Medical College. Mice were induced with isoflurane (2–4%) in 70% N2:30% O2 by facemask. After induction, the animal was maintained under isoflurane anesthesia using a small mask at ~1.5%. Animals were mounted in a stereotaxic frame. The heart rate, arterial blood oxygen saturation, and end-tidal CO2 were monitored and maintained at normal values throughout the experiment. Temperature was monitored rectally and maintained at 37°C with a homeothermic blanket system (Harvard Apparatus, Holliston MA). A ~ 4 × 5 mm cranial window was opened over one hemisphere between Lambda and Bregma to expose the neocortex. The dura was carefully removed. Ruthenium-bipyridine-triphenylphosphine caged 4-aminopyridine (RuBi-4-AP) (200 μl, 10 mM) was topically applied or microinjected into neocortex at least 30 min before uncaging. For the focal illumination, 2 μl RuBi-4-AP solution was injected in neocortex at the depth of 300 μm using an UltraMicroPump (UMP-3, WPI, Sarasota, FL) via a glass electrode controlled at a speed of 100 nl/min. For control experiments, 4-AP ictal discharges were induced by injecting 4-AP (Sigma, 15 mM, 0.5 μl) at the same location using a Nanoject II injector as previously described (Schwartz and Bonhoeffer, 2001 (link); Zhao et al., 2009 (link)).
Free full text: Click here